Awesome news!
A study on a new stem cell heart failure treatment presented at an American Heart Association meeting may be “the biggest thing in heart failure in 10 years.├óΓé¼┬¥
Revascor, paired with standard treatment, can reduce the risk of a patient’s heart failure occurrences by as much as 80%!
Heart failure is a long-term chronic condition that prevents the organ from effectively pumping blood.
While the experimental drug — developed by an Australian pharmaceutical company Mesoblast Ltd. — won’t hit the market until at least 2015, research has found the therapy was safe and well-tolerated at all doses.
Nov 15, 2011 16:00pm PDT
